contact%20dermatitis
CONTACT DERMATITIS

Contact dermatitis is an inflammation of the skin that can be acute or chronic that manifests as eczematous dermatitis due to exposure to substances in the environment.

Allergic contact dermatitis is an immunologic cell-mediated skin reaction to exposure to antigenic substances.
The lesions initially appear on the cutaneous site of principal exposure then may spread to other more distant sites due to contact or autosensitization. Lesions are typically asymmetrical and unilateral.
Specific signs and symptoms will depend on the duration, location, degree of sensitivity and concentration of allergens. The patch test shows reaction to allergen.
Irritant contact dermatitis is a non-immunologic skin reaction to skin irritants.
It is often localized to areas of thin skin eg eyelids, intertriginous areas.

Diagnosis

Allergic Contact Dermatitis

  • An immunologic cell-mediated skin reaction to exposure of antigenic substances; patch test positive

Irritant Contact Dermatitis

  • A nonimmunologic skin reaction to skin irritants; patch test negative

Differentiating between Allergic Contact Dermatitis & Irritant Contact Dermatitis:

  Allergic Contact Dermatitis Irritant Contact Dermatitis
Risk group Genetically predisposed Everyone
Mechanism of response Immunological response: Delayed hypersensitivity reactions Non-immunologic: Physical & chemical alteration of the skin epidermis
Nature of exposure Can be very low conc of low molecular wt hapten (eg metals, formalin, epoxy) after one or many exposures Normally high conc of organic solvent or soaps, etc after few to many exposures
Onset Usually hr to days Usually min to hr
Distribution May correspond exactly to contactant (eg elastic waist band, wristband) Indistinct borders
Diagnostic Test Based on patch test or usage test Based on trial of avoidance or negative patch test
Management Complete avoidance Protection & reduced incidence of exposure

History

Determine trigger factors based on:

  • Medical history
  • Physical exam
  • Questioning on the relationship between skin condition & include:
    • Date of onset
    • Occupation
    • Skin care products
  • Patch testing
    • Recommended in cases where symptoms persist despite avoidance of trigger factors & topical therapy
    • Not recommended as a diagnostic test for ICD
Editor's Recommendations
Most Read Articles
15 Jan 2018
Body surface area (BSA) affected by psoriasis can be measured to target diabetes prevention efforts for patients with psoriasis, a recent study suggests.
Pearl Toh, 14 Apr 2018
Taking the oral extract product of the fern Polypodium leucotomos (PLE) on top of the standard topical hydroquinone cream and sunscreen reduces the severity of melasma to a greater extent compared with the standard treatment alone in Asian patients, a pilot study has shown.
Stephen Padilla, 18 Apr 2018
High use of hydrochlorothiazide (HCTZ) appears to significantly increase the risk of nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), suggests a recent study. Use of other diuretic and antihypertensive medications does not appear to be linked to NMSC.
01 Jun 2013

An article by the same team in Leeds (see above) addresses the question of swabs for the diagnosis of gonorrhoea in the cohort of 3,973 women.